|
|
|
Volumn 22, Issue SUPPL. 4, 1998, Pages
|
|
High-dose chemotherapy with autologous hematopoietic progenitor cell transplantation in children with high-risk NHL and ALL - Preliminary results
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BUSULFAN;
CARMUSTINE;
CD34 ANTIGEN;
CYCLOPHOSPHAMIDE;
CYTARABINE;
ETOPOSIDE;
MAFOSFAMIDE;
MELPHALAN;
RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;
ACUTE LYMPHOCYTIC LEUKEMIA;
ADOLESCENT;
ADULT;
AUTOLOGOUS BONE MARROW TRANSPLANTATION;
BONE MARROW PURGING;
CANCER CHEMOTHERAPY;
CANCER MORTALITY;
CANCER REGRESSION;
CANCER SURVIVAL;
CAUSE OF DEATH;
CELL SEPARATION;
CHILD;
CLINICAL ARTICLE;
CLINICAL PROTOCOL;
CONFERENCE PAPER;
DEVICE;
FEMALE;
GRANULOCYTE;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HUMAN;
HUMAN CELL;
MALE;
NONHODGKIN LYMPHOMA;
PRIORITY JOURNAL;
RELAPSE;
THROMBOCYTE FUNCTION;
ADOLESCENT;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BUSULFAN;
CHILD;
CHILD, PRESCHOOL;
CYCLOSPORINE;
ETOPOSIDE;
FEMALE;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HUMANS;
LEUKEMIA, LYMPHOCYTIC, ACUTE, L1;
LYMPHOMA, NON-HODGKIN;
MALE;
PLATELET COUNT;
SURVIVAL RATE;
TRANSPLANTATION, AUTOLOGOUS;
TREATMENT OUTCOME;
|
|
EID: 0032423126
PISSN: 02683369
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (2)
|
|
References (6)
|
